Docs are excited about CAR-T, BTK drugs, survey finds. How can pharma best promote them?

What did docs think was hot this year at the American Society of Hematology (ASH) annual meeting? InCrowd polled oncologists and hematologists immediately after the December conference and found that multiple myeloma received the most mentions for exciting data or developments presented.